VCANBIO CELL & GENE ENGINEERING CORP., LTD Funds and ETFs Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.8 CNY | +4.89% |
|
+8.21% | -12.19% |
ETFs positioned on Vcanbio Cell & Gene Engineering Corp., Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.67% | - |
VCANBIO CELL & GENE ENGINEERING CORP., LTD is a China-based company, principally engaged in the preparation, detection and storage of cells. The Company is also engaged in cell culture and gene detection and storage, as well as the production and sale of cytokines culture solutions, cosmetics and detection reagents. The Company conducts its businesses mainly within domestic markets.
Calendar
2024-05-19
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -12.19% | 1.15B | |
| -1.89% | 12.56B | |
| -9.59% | 7.68B | |
| -1.31% | 5.29B | |
| +21.82% | 5.18B | |
| +0.02% | 4.57B | |
| -50.89% | 3.29B | |
| +6.42% | 2.6B | |
| -10.02% | 2.2B | |
| -8.29% | 1.79B |
- Stock Market
- Equities
- 600645 Stock
- Funds and ETFs Vcanbio Cell & Gene Engineering Corp., Ltd
